By Editor , 28 September 2026
IDEAYA Biosciences Promotes Michael White to President, R&D

South San Francisco, Calif. – September 28, 2026 -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA) promoted Dr. Michael White from Chief Scientific Officer to President, Research and Development, effective September 28, 2026.

By Editor , 23 September 2026
Lupus Nephritis Market to Reach $4.08B by 2034, 8.5% CAGR

Pune, India – September 22, 2026 -- The global lupus nephritis market was valued at $1.96 billion in 2025 and is projected to reach $4.08 billion by 2034, expanding at a compound annual growth rate of 8.5% through the forecast period, according to a new analysis by Maximize Market Research.

By Editor , 18 September 2026
NCCN, Pfizer Fund Four Quality Projects to Close mPCA Care Gaps

Plymouth Meeting, Pa. – September 17, 2026 -- The National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded funding for four quality improvement projects targeting metastatic prostate cancer (mPCA) care, backed by Pfizer Global Medical Grants (GMG).